Kaposi's sarcoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Raviteja Reddy Guddeti (talk | contribs)
nocaptcha
20,348 edits
No edit summary
Rim Halaby (talk | contribs)
CMEUser, Bureaucrats, nocaptcha, Administrators
27,346 edits
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Kaposi's sarcoma}}
{{Kaposi's sarcoma}}
{{CMG}}; {{AE}} {{Rim}}
==Overview==
==Epidemiology and Demographics==
===Prevalence===
* In the United States, the age adjusted prevalence of Kaposi sarcoma is 0.0081% in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
===Incidence===
* In 2011, the age-adjusted incidence of Kaposi sarcoma was 0.64 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
===Age===
* While the overall age adjusted incidence of Kaposi sarcoma in the United States between 2007 and 2011 is 0.5 per 100,000, the age-adjusted incidence of Kaposi sarcoma by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** Under 65 years: 0.5 per 100,000
** 65 and over: 1 per 100,000
===Gender===
* In the United States, the age adjusted prevalence of Kaposi sarcoma by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In males: 0.016%
** In females: 0.0006%
===Race===
* Shown below is a table depicting the age adjusted prevalence of Kaposi sarcoma by race in 2011 in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Asian/Pacific Islander'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''
|-
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age-adjusted prevalence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0081% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0080% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0.0124%||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.002% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.0111
|}


Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:HIV/AIDS]]
[[Category:HIV/AIDS]]

Revision as of 17:20, 11 June 2014

Kaposi's sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kaposi's sarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Kaposi's sarcoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kaposi's sarcoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kaposi's sarcoma epidemiology and demographics

CDC on Kaposi's sarcoma epidemiology and demographics

Kaposi's sarcoma epidemiology and demographics in the news

Blogs on Kaposi's sarcoma epidemiology and demographics

Directions to Hospitals Treating Kaposi's sarcoma

Risk calculators and risk factors for Kaposi's sarcoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

  • In the United States, the age adjusted prevalence of Kaposi sarcoma is 0.0081% in 2011.[1]

Incidence

  • In 2011, the age-adjusted incidence of Kaposi sarcoma was 0.64 per 100,000 persons in the United States.[1]

Age

  • While the overall age adjusted incidence of Kaposi sarcoma in the United States between 2007 and 2011 is 0.5 per 100,000, the age-adjusted incidence of Kaposi sarcoma by age category is:[1]
    • Under 65 years: 0.5 per 100,000
    • 65 and over: 1 per 100,000

Gender

  • In the United States, the age adjusted prevalence of Kaposi sarcoma by gender in 2011 is:[1]
    • In males: 0.016%
    • In females: 0.0006%

Race

  • Shown below is a table depicting the age adjusted prevalence of Kaposi sarcoma by race in 2011 in the United States.[1]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 0.0081% 0.0080% 0.0124% 0.002% 0.0111

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Kaposi%27s_sarcoma_epidemiology_and_demographics&oldid=977494"